Innovating Works

DECODE GENETICS EHF

Desconocido
Showing 1 to 20 of 45 results
REALMENT: Using real world big data from eHealth biobanks and national registries integrated with clinical t... ISLENSK ERFDAGREINING EHF participó en un H2020 H2020-SC1-BHC-2018-2020 Mental disorders represent one of the largest burdens for the European Health Care system, due to large number of patients and a lack of eff...
2021-01-29 - 2025-11-30 | Financiado
PainFACT: Molecular Mechanisms Associating Chronic Pain with Fatigue Affective Disorders Cardiovascular Dise... Chronic pain (CP) is the leading cause of disability, and is strongly associated with fatigue, anxiety and depression ─ also major contribut...
2019-11-22 - 2025-12-31 | Financiado
CoMorMent: Predicting comorbid cardiovascular disease in individuals with mental disorder by decoding disease m... ISLENSK ERFDAGREINING EHF participó en un H2020 H2020-SC1-BHC-2018-2020 Comorbid cardiovascular disease in people with severe mental disorders is a major public health concern and poses a considerable financial b...
2019-11-21 - 2024-12-31 | Financiado
ImPRESS: International Interdisciplinary PhD studies in Biomedical Research and Biostatistics. Supporting the... ISLENSK ERFDAGREINING EHF participó en un H2020 H2020-MSCA-COFUND-2016 The aim of the project is to launch Interdisciplinary PhD Studies in Biomedicine aimed at young aspiring scientists, who will conduct resear...
2017-05-12 - 2023-01-31 | Financiado
STEMBANCC: Stem cells for Biological Assays of Novel drugs and prediCtive toxiCology (StemBANCC) ISLENSK ERFDAGREINING EHF participó en un FP6 StemBANCC, comprising internationally renowned investigators, is ideally positioned to deliver a unique European biorepository and drug disc...
2012-10-01 - 2018-03-31 | Financiado
EU-AIMS: European Autism Interventions - A Multicentre Study for Developing New Medications ISLENSK ERFDAGREINING EHF participó en un FP6 Despite dramatic advances in molecular and imaging technologies, there are currently no effective pharmacological treatments for the core sy...
2012-04-01 - 2018-03-31 | Financiado
BIOVACSAFE: Biomarkers For Enhanced Vaccine Safety ISLENSK ERFDAGREINING EHF participó en un FP6 BioVacSafe is a concise consortium of selected academic, public, and SME participants used to co-working in industry-led projects, organised...
2012-03-01 - 2018-08-31 | Financiado
NEWMEDS: Novel Methods leading to New Medications in Depression and Schizophrenia ISLENSK ERFDAGREINING EHF participó en un FP6 Despite dramatic advances in molecular and imaging technologies and nearly 1 5,000 articles on schizophrenia and depression (S&D) there are...
2009-09-01 - 2015-02-28 | Financiado
PSYCHCNVS: Copy number variations conferring risk of psychiatric disorders in children ISLENSK ERFDAGREINING EHF tramitó un FP7 The recent technical improvements for the study of the cytogenetic basis of disease have led to the identification of many microdeletion and...
Financiado
PSYCHDPC: Psychiatric Diagnostic and Prevention Consortium ISLENSK ERFDAGREINING EHF tramitó un FP7 PsychDPC contains leading European centres in genetics and psychiatry, richly endowed with expertise in both clinical and basic research. Th...
Financiado
PROMARK: Genetic prostate cancer variants as biomarkers of disease progression ISLENSK ERFDAGREINING EHF tramitó un FP7 Prostate cancer is the most common cancer in males in Europe, causing over 87,000 deaths in 2006. Early diagnosis and treatment are key fact...
Financiado
PSYCHGENE: Copy Number Variation and Endophenotypes in Psychiatric Disorders ISLENSK ERFDAGREINING EHF tramitó un FP7 A genome-wide copy number variant (CNV) association study for schizophrenia (SZ), bipolar disorder (BP) and major depression (MD) will be co...
Financiado
CANCERGENE: Identification and functional characterization of genetic cancer risk variants ISLENSK ERFDAGREINING EHF tramitó un FP7 This Industry-Academia Partnership and Pathways (IAPP) joins three groups which have hitherto focused on different aspects of cancer genetic...
Financiado
NEWMEDS: Novel Methods leading to New Medications in Depression and Schizophrenia ISLENSK ERFDAGREINING EHF participó en un FP7 Despite dramatic advances in molecular and imaging technologies and nearly 1 5,000 articles on schizophrenia and depression (S&D) there are...
Financiado
BBMRI-LPC: BBMRI Large Prospective Cohorts ISLENSK ERFDAGREINING EHF participó en un FP7 In recent years, biomedical research has crossed international borders in large, collaborative studies showing the value of multidisciplinar...
Financiado
ENGAGE: European Network for Genetic and Genomic Epidemiology ISLENSK ERFDAGREINING EHF participó en un FP7 ENGAGE (European Network for Genetic and Genomic Epidemiology) has, as its central objective, the translation of the wealth of data emerging...
Financiado
INTERPREGGEN: Genetic studies of pre eclampsia in Central Asian and European populations ISLENSK ERFDAGREINING EHF participó en un FP7 Pre-eclampsia, one of the most dangerous cardiometabolic complications of pregnancy, claims the lives of 50,000 mothers and almost one milli...
Financiado
GEN2PHEN: Genotype To Phenotype Databases A Holistic Solution ISLENSK ERFDAGREINING EHF participó en un FP7 The GEN2PHEN project aims to unify human and model organism genetic variation databases towards increasingly holistic views into Genotype-To...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.